ClinicalTrials.Veeva

Menu

Tzanck Smear With Methylene Blue Stain for Herpes

C

Chulalongkorn University

Status and phase

Unknown
Phase 3

Conditions

Herpes Simplex
Varicella Zoster
Herpes Zoster

Treatments

Diagnostic Test: Giemsa stain
Diagnostic Test: Methylene blue

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

To compare the sensitivity of Tzanck smear with methylene blue stain versus traditional Giemsa stain in patients with herpes infection.

Full description

A smear from the lesional skin of the patients suspected having Herpes simplex, Herpes zoster and Varicella zoster skin infections will be collected (in a clinical routine setting). The specimen will be stained with methylene blue in addition to the Giemsa stain. Polymerase chain reaction study for herpes antigen will be performed in some of the specimens. The sensitivity, specificity, positive predictive value and negative predictive value will be calculated from the results of the study.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with clinically suspected of having herpes simplex, herpes zoster, varicella zoster skin infections.
  • Those who have vesicular skin lesion such as acute eczema, Paederus dermatitis.
  • Those are well cooperative.
  • Age > 18 years old.

Exclusion criteria

  • Those who are not willing to have specimen from skin lesions to be collected.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

150 participants in 2 patient groups

Case
Active Comparator group
Description:
Patients who clinically diagnosed as herpes simplex, herpes zoster or varicella zoster skin infection.
Treatment:
Diagnostic Test: Giemsa stain
Diagnostic Test: Methylene blue
Negative control
Sham Comparator group
Description:
Patients who develops vesicular lesion but not typically considered as herpesviral skin infection, such as acute eczema, Paederus dermatitis
Treatment:
Diagnostic Test: Giemsa stain
Diagnostic Test: Methylene blue

Trial contacts and locations

1

Loading...

Central trial contact

Pawinee Rerknimitr, MD, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems